928064-71-5 Usage
Uses
Used in Pharmaceutical Industry:
(3S)-2-Hydroxy-3-[[(benzyloxy)carbonyl]amino]hexanoic Acid Methyl Ester is used as a key intermediate in the synthesis of serine protease inhibitors for the pharmaceutical industry. Its unique structure allows for the development of compounds that can effectively inhibit the activity of serine proteases, which are important targets for various therapeutic applications, including the treatment of inflammatory diseases, coagulation disorders, and cancer.
Used in Research and Development:
In the field of research and development, (3S)-2-Hydroxy-3-[[(benzyloxy)carbonyl]amino]hexanoic Acid Methyl Ester serves as a valuable building block for the creation of novel serine protease inhibitors with improved potency, selectivity, and pharmacokinetic properties. Its synthesis and modification can lead to the discovery of new drugs with better efficacy and safety profiles.
Used in Biochemistry and Enzymology:
(3S)-2-Hydroxy-3-[[(benzyloxy)carbonyl]amino]hexanoic Acid Methyl Ester is also utilized in biochemical and enzymological studies to investigate the mechanisms of serine protease inhibition and to understand the structure-activity relationships of these enzymes. This knowledge can contribute to the design of more effective and selective inhibitors for various biological applications.
Check Digit Verification of cas no
The CAS Registry Mumber 928064-71-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,8,0,6 and 4 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 928064-71:
(8*9)+(7*2)+(6*8)+(5*0)+(4*6)+(3*4)+(2*7)+(1*1)=185
185 % 10 = 5
So 928064-71-5 is a valid CAS Registry Number.
928064-71-5Relevant academic research and scientific papers
SYNTHESIS OF AN INTERMEDIATE OF AN ANTIVIRAL COMPOUND
-
Page/Page column 25-26, (2013/09/26)
Process for the preparation of a cyclopropylamide compound which is useful as a structural unit in a process for the preparation of a viral protease inhibitor.
